Open AccessZanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
Author(s) -
Lijie Xing,
Qingfeng He,
Lin-Na Xie,
Hui Wang,
Zengjun Li
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280259
Subject(s) - lenalidomide , rituximab , medicine , prolymphocytic leukemia , oncology , cancer research , leukemia , multiple myeloma , chronic lymphocytic leukemia , lymphoma
Not available.